 | • レポートコード：MRC308GR11549 • 出版社/出版日：GlobalInfoResearch / 2023年8月 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール（2-3営業日） • 産業分類：医薬品＆ヘルスケア |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
GlobalInfoResearchの最新の調査によると、世界のリバーロキサバン錠の市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
このレポートは、世界のリバーロキサバン錠市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、種類別、用途別に記載されています。
市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。
本レポートの主な目的は次のとおりです。
– 世界および主要国の市場機会の規模を決定するため
– リバーロキサバン錠の成長可能性を評価するため
– 各製品および最終用途市場の将来の成長を予測するため
– 市場に影響を与える競争要因を評価するため
リバーロキサバン錠市場は種類と用途によって区分されます。2018年～2029年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。
種類別セグメント
・2.5mg/錠、10mg/錠、15mg/錠、20mg/錠
用途別セグメント
・病院、診療所、ドラッグストア
主要な市場プレーヤー
・Bayer、Janssen Pharmaceuticals、Beijing SL Pharmaceutical、Nanjing Zhengda Tianqing Pharmaceutical、Fujian Cosunter Pharmaceutical、Lunan Pharmaceutical、Shanghai Huilun Pharmaceutical、Jilin Boda Pharmaceutical、Cspc Holdings Company、Zhejiang Conba Pharmaceutical、Suzhou No.3 Pharmaceutical、Chengdu Baiyu Pharmaceuticals、Jiangsu Zhongbang Pharmaceutical
地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）
本調査レポートの内容は計15章あります。
・第1章では、リバーロキサバン錠製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なリバーロキサバン錠メーカーの企業概要、2019年～2022年までのリバーロキサバン錠の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なリバーロキサバン錠メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年～2029年までの地域別リバーロキサバン錠の販売量、売上、成長性を示しています。
・第5、6章では、2018年～2029年までのリバーロキサバン錠の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域でのリバーロキサバン錠市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、およびリバーロキサバン錠の産業チェーンを掲載しています。
・第14、15章では、リバーロキサバン錠の販売チャネル、販売業者、顧客、調査結果について説明します。
***** 目次(一部) *****
・市場概要
– リバーロキサバン錠の概要
– 種類別分析（2018年vs2022年vs2029年）：2.5mg/錠、10mg/錠、15mg/錠、20mg/錠
– 用途別分析（2018年vs2022年vs2029年）：病院、診療所、ドラッグストア
– 世界のリバーロキサバン錠市場規模・予測
– 世界のリバーロキサバン錠生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– Bayer、Janssen Pharmaceuticals、Beijing SL Pharmaceutical、Nanjing Zhengda Tianqing Pharmaceutical、Fujian Cosunter Pharmaceutical、Lunan Pharmaceutical、Shanghai Huilun Pharmaceutical、Jilin Boda Pharmaceutical、Cspc Holdings Company、Zhejiang Conba Pharmaceutical、Suzhou No.3 Pharmaceutical、Chengdu Baiyu Pharmaceuticals、Jiangsu Zhongbang Pharmaceutical
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・種類別分析2018年-2029年：2.5mg/錠、10mg/錠、15mg/錠、20mg/錠
・用途別分析2018年-2029年：病院、診療所、ドラッグストア
・リバーロキサバン錠の北米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・リバーロキサバン錠のヨーロッパ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・リバーロキサバン錠のアジア市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・リバーロキサバン錠の南米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・リバーロキサバン錠の中東・アフリカ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析）
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論
1 Market Overview
1.1 Product Overview and Scope of Rivaroxaban Tablets
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Rivaroxaban Tablets Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 2.5mg/Tablet
1.3.3 10mg/Tablet
1.3.4 15mg/Tablet
1.3.5 20mg/Tablet
1.4 Market Analysis by Application
1.4.1 Overview: Global Rivaroxaban Tablets Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Drugstore
1.5 Global Rivaroxaban Tablets Market Size & Forecast
1.5.1 Global Rivaroxaban Tablets Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Rivaroxaban Tablets Sales Quantity (2018-2029)
1.5.3 Global Rivaroxaban Tablets Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Bayer
2.1.1 Bayer Details
2.1.2 Bayer Major Business
2.1.3 Bayer Rivaroxaban Tablets Product and Services
2.1.4 Bayer Rivaroxaban Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Bayer Recent Developments/Updates
2.2 Janssen Pharmaceuticals
2.2.1 Janssen Pharmaceuticals Details
2.2.2 Janssen Pharmaceuticals Major Business
2.2.3 Janssen Pharmaceuticals Rivaroxaban Tablets Product and Services
2.2.4 Janssen Pharmaceuticals Rivaroxaban Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Janssen Pharmaceuticals Recent Developments/Updates
2.3 Beijing SL Pharmaceutical
2.3.1 Beijing SL Pharmaceutical Details
2.3.2 Beijing SL Pharmaceutical Major Business
2.3.3 Beijing SL Pharmaceutical Rivaroxaban Tablets Product and Services
2.3.4 Beijing SL Pharmaceutical Rivaroxaban Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Beijing SL Pharmaceutical Recent Developments/Updates
2.4 Nanjing Zhengda Tianqing Pharmaceutical
2.4.1 Nanjing Zhengda Tianqing Pharmaceutical Details
2.4.2 Nanjing Zhengda Tianqing Pharmaceutical Major Business
2.4.3 Nanjing Zhengda Tianqing Pharmaceutical Rivaroxaban Tablets Product and Services
2.4.4 Nanjing Zhengda Tianqing Pharmaceutical Rivaroxaban Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Nanjing Zhengda Tianqing Pharmaceutical Recent Developments/Updates
2.5 Fujian Cosunter Pharmaceutical
2.5.1 Fujian Cosunter Pharmaceutical Details
2.5.2 Fujian Cosunter Pharmaceutical Major Business
2.5.3 Fujian Cosunter Pharmaceutical Rivaroxaban Tablets Product and Services
2.5.4 Fujian Cosunter Pharmaceutical Rivaroxaban Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Fujian Cosunter Pharmaceutical Recent Developments/Updates
2.6 Lunan Pharmaceutical
2.6.1 Lunan Pharmaceutical Details
2.6.2 Lunan Pharmaceutical Major Business
2.6.3 Lunan Pharmaceutical Rivaroxaban Tablets Product and Services
2.6.4 Lunan Pharmaceutical Rivaroxaban Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Lunan Pharmaceutical Recent Developments/Updates
2.7 Shanghai Huilun Pharmaceutical
2.7.1 Shanghai Huilun Pharmaceutical Details
2.7.2 Shanghai Huilun Pharmaceutical Major Business
2.7.3 Shanghai Huilun Pharmaceutical Rivaroxaban Tablets Product and Services
2.7.4 Shanghai Huilun Pharmaceutical Rivaroxaban Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Shanghai Huilun Pharmaceutical Recent Developments/Updates
2.8 Jilin Boda Pharmaceutical
2.8.1 Jilin Boda Pharmaceutical Details
2.8.2 Jilin Boda Pharmaceutical Major Business
2.8.3 Jilin Boda Pharmaceutical Rivaroxaban Tablets Product and Services
2.8.4 Jilin Boda Pharmaceutical Rivaroxaban Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Jilin Boda Pharmaceutical Recent Developments/Updates
2.9 Cspc Holdings Company
2.9.1 Cspc Holdings Company Details
2.9.2 Cspc Holdings Company Major Business
2.9.3 Cspc Holdings Company Rivaroxaban Tablets Product and Services
2.9.4 Cspc Holdings Company Rivaroxaban Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Cspc Holdings Company Recent Developments/Updates
2.10 Zhejiang Conba Pharmaceutical
2.10.1 Zhejiang Conba Pharmaceutical Details
2.10.2 Zhejiang Conba Pharmaceutical Major Business
2.10.3 Zhejiang Conba Pharmaceutical Rivaroxaban Tablets Product and Services
2.10.4 Zhejiang Conba Pharmaceutical Rivaroxaban Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Zhejiang Conba Pharmaceutical Recent Developments/Updates
2.11 Suzhou No.3 Pharmaceutical
2.11.1 Suzhou No.3 Pharmaceutical Details
2.11.2 Suzhou No.3 Pharmaceutical Major Business
2.11.3 Suzhou No.3 Pharmaceutical Rivaroxaban Tablets Product and Services
2.11.4 Suzhou No.3 Pharmaceutical Rivaroxaban Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Suzhou No.3 Pharmaceutical Recent Developments/Updates
2.12 Chengdu Baiyu Pharmaceuticals
2.12.1 Chengdu Baiyu Pharmaceuticals Details
2.12.2 Chengdu Baiyu Pharmaceuticals Major Business
2.12.3 Chengdu Baiyu Pharmaceuticals Rivaroxaban Tablets Product and Services
2.12.4 Chengdu Baiyu Pharmaceuticals Rivaroxaban Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Chengdu Baiyu Pharmaceuticals Recent Developments/Updates
2.13 Jiangsu Zhongbang Pharmaceutical
2.13.1 Jiangsu Zhongbang Pharmaceutical Details
2.13.2 Jiangsu Zhongbang Pharmaceutical Major Business
2.13.3 Jiangsu Zhongbang Pharmaceutical Rivaroxaban Tablets Product and Services
2.13.4 Jiangsu Zhongbang Pharmaceutical Rivaroxaban Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Jiangsu Zhongbang Pharmaceutical Recent Developments/Updates
3 Competitive Environment: Rivaroxaban Tablets by Manufacturer
3.1 Global Rivaroxaban Tablets Sales Quantity by Manufacturer (2018-2023)
3.2 Global Rivaroxaban Tablets Revenue by Manufacturer (2018-2023)
3.3 Global Rivaroxaban Tablets Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Rivaroxaban Tablets by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Rivaroxaban Tablets Manufacturer Market Share in 2022
3.4.2 Top 6 Rivaroxaban Tablets Manufacturer Market Share in 2022
3.5 Rivaroxaban Tablets Market: Overall Company Footprint Analysis
3.5.1 Rivaroxaban Tablets Market: Region Footprint
3.5.2 Rivaroxaban Tablets Market: Company Product Type Footprint
3.5.3 Rivaroxaban Tablets Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Rivaroxaban Tablets Market Size by Region
4.1.1 Global Rivaroxaban Tablets Sales Quantity by Region (2018-2029)
4.1.2 Global Rivaroxaban Tablets Consumption Value by Region (2018-2029)
4.1.3 Global Rivaroxaban Tablets Average Price by Region (2018-2029)
4.2 North America Rivaroxaban Tablets Consumption Value (2018-2029)
4.3 Europe Rivaroxaban Tablets Consumption Value (2018-2029)
4.4 Asia-Pacific Rivaroxaban Tablets Consumption Value (2018-2029)
4.5 South America Rivaroxaban Tablets Consumption Value (2018-2029)
4.6 Middle East and Africa Rivaroxaban Tablets Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Rivaroxaban Tablets Sales Quantity by Type (2018-2029)
5.2 Global Rivaroxaban Tablets Consumption Value by Type (2018-2029)
5.3 Global Rivaroxaban Tablets Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Rivaroxaban Tablets Sales Quantity by Application (2018-2029)
6.2 Global Rivaroxaban Tablets Consumption Value by Application (2018-2029)
6.3 Global Rivaroxaban Tablets Average Price by Application (2018-2029)
7 North America
7.1 North America Rivaroxaban Tablets Sales Quantity by Type (2018-2029)
7.2 North America Rivaroxaban Tablets Sales Quantity by Application (2018-2029)
7.3 North America Rivaroxaban Tablets Market Size by Country
7.3.1 North America Rivaroxaban Tablets Sales Quantity by Country (2018-2029)
7.3.2 North America Rivaroxaban Tablets Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Rivaroxaban Tablets Sales Quantity by Type (2018-2029)
8.2 Europe Rivaroxaban Tablets Sales Quantity by Application (2018-2029)
8.3 Europe Rivaroxaban Tablets Market Size by Country
8.3.1 Europe Rivaroxaban Tablets Sales Quantity by Country (2018-2029)
8.3.2 Europe Rivaroxaban Tablets Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Rivaroxaban Tablets Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Rivaroxaban Tablets Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Rivaroxaban Tablets Market Size by Region
9.3.1 Asia-Pacific Rivaroxaban Tablets Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Rivaroxaban Tablets Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Rivaroxaban Tablets Sales Quantity by Type (2018-2029)
10.2 South America Rivaroxaban Tablets Sales Quantity by Application (2018-2029)
10.3 South America Rivaroxaban Tablets Market Size by Country
10.3.1 South America Rivaroxaban Tablets Sales Quantity by Country (2018-2029)
10.3.2 South America Rivaroxaban Tablets Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Rivaroxaban Tablets Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Rivaroxaban Tablets Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Rivaroxaban Tablets Market Size by Country
11.3.1 Middle East & Africa Rivaroxaban Tablets Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Rivaroxaban Tablets Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Rivaroxaban Tablets Market Drivers
12.2 Rivaroxaban Tablets Market Restraints
12.3 Rivaroxaban Tablets Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Rivaroxaban Tablets and Key Manufacturers
13.2 Manufacturing Costs Percentage of Rivaroxaban Tablets
13.3 Rivaroxaban Tablets Production Process
13.4 Rivaroxaban Tablets Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Rivaroxaban Tablets Typical Distributors
14.3 Rivaroxaban Tablets Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table 1. Global Rivaroxaban Tablets Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Rivaroxaban Tablets Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Bayer Basic Information, Manufacturing Base and Competitors
Table 4. Bayer Major Business
Table 5. Bayer Rivaroxaban Tablets Product and Services
Table 6. Bayer Rivaroxaban Tablets Sales Quantity (K Boxes), Average Price (US$/Box), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Bayer Recent Developments/Updates
Table 8. Janssen Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 9. Janssen Pharmaceuticals Major Business
Table 10. Janssen Pharmaceuticals Rivaroxaban Tablets Product and Services
Table 11. Janssen Pharmaceuticals Rivaroxaban Tablets Sales Quantity (K Boxes), Average Price (US$/Box), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Janssen Pharmaceuticals Recent Developments/Updates
Table 13. Beijing SL Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 14. Beijing SL Pharmaceutical Major Business
Table 15. Beijing SL Pharmaceutical Rivaroxaban Tablets Product and Services
Table 16. Beijing SL Pharmaceutical Rivaroxaban Tablets Sales Quantity (K Boxes), Average Price (US$/Box), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Beijing SL Pharmaceutical Recent Developments/Updates
Table 18. Nanjing Zhengda Tianqing Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 19. Nanjing Zhengda Tianqing Pharmaceutical Major Business
Table 20. Nanjing Zhengda Tianqing Pharmaceutical Rivaroxaban Tablets Product and Services
Table 21. Nanjing Zhengda Tianqing Pharmaceutical Rivaroxaban Tablets Sales Quantity (K Boxes), Average Price (US$/Box), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Nanjing Zhengda Tianqing Pharmaceutical Recent Developments/Updates
Table 23. Fujian Cosunter Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 24. Fujian Cosunter Pharmaceutical Major Business
Table 25. Fujian Cosunter Pharmaceutical Rivaroxaban Tablets Product and Services
Table 26. Fujian Cosunter Pharmaceutical Rivaroxaban Tablets Sales Quantity (K Boxes), Average Price (US$/Box), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Fujian Cosunter Pharmaceutical Recent Developments/Updates
Table 28. Lunan Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 29. Lunan Pharmaceutical Major Business
Table 30. Lunan Pharmaceutical Rivaroxaban Tablets Product and Services
Table 31. Lunan Pharmaceutical Rivaroxaban Tablets Sales Quantity (K Boxes), Average Price (US$/Box), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Lunan Pharmaceutical Recent Developments/Updates
Table 33. Shanghai Huilun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 34. Shanghai Huilun Pharmaceutical Major Business
Table 35. Shanghai Huilun Pharmaceutical Rivaroxaban Tablets Product and Services
Table 36. Shanghai Huilun Pharmaceutical Rivaroxaban Tablets Sales Quantity (K Boxes), Average Price (US$/Box), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Shanghai Huilun Pharmaceutical Recent Developments/Updates
Table 38. Jilin Boda Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 39. Jilin Boda Pharmaceutical Major Business
Table 40. Jilin Boda Pharmaceutical Rivaroxaban Tablets Product and Services
Table 41. Jilin Boda Pharmaceutical Rivaroxaban Tablets Sales Quantity (K Boxes), Average Price (US$/Box), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Jilin Boda Pharmaceutical Recent Developments/Updates
Table 43. Cspc Holdings Company Basic Information, Manufacturing Base and Competitors
Table 44. Cspc Holdings Company Major Business
Table 45. Cspc Holdings Company Rivaroxaban Tablets Product and Services
Table 46. Cspc Holdings Company Rivaroxaban Tablets Sales Quantity (K Boxes), Average Price (US$/Box), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Cspc Holdings Company Recent Developments/Updates
Table 48. Zhejiang Conba Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 49. Zhejiang Conba Pharmaceutical Major Business
Table 50. Zhejiang Conba Pharmaceutical Rivaroxaban Tablets Product and Services
Table 51. Zhejiang Conba Pharmaceutical Rivaroxaban Tablets Sales Quantity (K Boxes), Average Price (US$/Box), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Zhejiang Conba Pharmaceutical Recent Developments/Updates
Table 53. Suzhou No.3 Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 54. Suzhou No.3 Pharmaceutical Major Business
Table 55. Suzhou No.3 Pharmaceutical Rivaroxaban Tablets Product and Services
Table 56. Suzhou No.3 Pharmaceutical Rivaroxaban Tablets Sales Quantity (K Boxes), Average Price (US$/Box), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Suzhou No.3 Pharmaceutical Recent Developments/Updates
Table 58. Chengdu Baiyu Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 59. Chengdu Baiyu Pharmaceuticals Major Business
Table 60. Chengdu Baiyu Pharmaceuticals Rivaroxaban Tablets Product and Services
Table 61. Chengdu Baiyu Pharmaceuticals Rivaroxaban Tablets Sales Quantity (K Boxes), Average Price (US$/Box), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Chengdu Baiyu Pharmaceuticals Recent Developments/Updates
Table 63. Jiangsu Zhongbang Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 64. Jiangsu Zhongbang Pharmaceutical Major Business
Table 65. Jiangsu Zhongbang Pharmaceutical Rivaroxaban Tablets Product and Services
Table 66. Jiangsu Zhongbang Pharmaceutical Rivaroxaban Tablets Sales Quantity (K Boxes), Average Price (US$/Box), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Jiangsu Zhongbang Pharmaceutical Recent Developments/Updates
Table 68. Global Rivaroxaban Tablets Sales Quantity by Manufacturer (2018-2023) & (K Boxes)
Table 69. Global Rivaroxaban Tablets Revenue by Manufacturer (2018-2023) & (USD Million)
Table 70. Global Rivaroxaban Tablets Average Price by Manufacturer (2018-2023) & (US$/Box)
Table 71. Market Position of Manufacturers in Rivaroxaban Tablets, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 72. Head Office and Rivaroxaban Tablets Production Site of Key Manufacturer
Table 73. Rivaroxaban Tablets Market: Company Product Type Footprint
Table 74. Rivaroxaban Tablets Market: Company Product Application Footprint
Table 75. Rivaroxaban Tablets New Market Entrants and Barriers to Market Entry
Table 76. Rivaroxaban Tablets Mergers, Acquisition, Agreements, and Collaborations
Table 77. Global Rivaroxaban Tablets Sales Quantity by Region (2018-2023) & (K Boxes)
Table 78. Global Rivaroxaban Tablets Sales Quantity by Region (2024-2029) & (K Boxes)
Table 79. Global Rivaroxaban Tablets Consumption Value by Region (2018-2023) & (USD Million)
Table 80. Global Rivaroxaban Tablets Consumption Value by Region (2024-2029) & (USD Million)
Table 81. Global Rivaroxaban Tablets Average Price by Region (2018-2023) & (US$/Box)
Table 82. Global Rivaroxaban Tablets Average Price by Region (2024-2029) & (US$/Box)
Table 83. Global Rivaroxaban Tablets Sales Quantity by Type (2018-2023) & (K Boxes)
Table 84. Global Rivaroxaban Tablets Sales Quantity by Type (2024-2029) & (K Boxes)
Table 85. Global Rivaroxaban Tablets Consumption Value by Type (2018-2023) & (USD Million)
Table 86. Global Rivaroxaban Tablets Consumption Value by Type (2024-2029) & (USD Million)
Table 87. Global Rivaroxaban Tablets Average Price by Type (2018-2023) & (US$/Box)
Table 88. Global Rivaroxaban Tablets Average Price by Type (2024-2029) & (US$/Box)
Table 89. Global Rivaroxaban Tablets Sales Quantity by Application (2018-2023) & (K Boxes)
Table 90. Global Rivaroxaban Tablets Sales Quantity by Application (2024-2029) & (K Boxes)
Table 91. Global Rivaroxaban Tablets Consumption Value by Application (2018-2023) & (USD Million)
Table 92. Global Rivaroxaban Tablets Consumption Value by Application (2024-2029) & (USD Million)
Table 93. Global Rivaroxaban Tablets Average Price by Application (2018-2023) & (US$/Box)
Table 94. Global Rivaroxaban Tablets Average Price by Application (2024-2029) & (US$/Box)
Table 95. North America Rivaroxaban Tablets Sales Quantity by Type (2018-2023) & (K Boxes)
Table 96. North America Rivaroxaban Tablets Sales Quantity by Type (2024-2029) & (K Boxes)
Table 97. North America Rivaroxaban Tablets Sales Quantity by Application (2018-2023) & (K Boxes)
Table 98. North America Rivaroxaban Tablets Sales Quantity by Application (2024-2029) & (K Boxes)
Table 99. North America Rivaroxaban Tablets Sales Quantity by Country (2018-2023) & (K Boxes)
Table 100. North America Rivaroxaban Tablets Sales Quantity by Country (2024-2029) & (K Boxes)
Table 101. North America Rivaroxaban Tablets Consumption Value by Country (2018-2023) & (USD Million)
Table 102. North America Rivaroxaban Tablets Consumption Value by Country (2024-2029) & (USD Million)
Table 103. Europe Rivaroxaban Tablets Sales Quantity by Type (2018-2023) & (K Boxes)
Table 104. Europe Rivaroxaban Tablets Sales Quantity by Type (2024-2029) & (K Boxes)
Table 105. Europe Rivaroxaban Tablets Sales Quantity by Application (2018-2023) & (K Boxes)
Table 106. Europe Rivaroxaban Tablets Sales Quantity by Application (2024-2029) & (K Boxes)
Table 107. Europe Rivaroxaban Tablets Sales Quantity by Country (2018-2023) & (K Boxes)
Table 108. Europe Rivaroxaban Tablets Sales Quantity by Country (2024-2029) & (K Boxes)
Table 109. Europe Rivaroxaban Tablets Consumption Value by Country (2018-2023) & (USD Million)
Table 110. Europe Rivaroxaban Tablets Consumption Value by Country (2024-2029) & (USD Million)
Table 111. Asia-Pacific Rivaroxaban Tablets Sales Quantity by Type (2018-2023) & (K Boxes)
Table 112. Asia-Pacific Rivaroxaban Tablets Sales Quantity by Type (2024-2029) & (K Boxes)
Table 113. Asia-Pacific Rivaroxaban Tablets Sales Quantity by Application (2018-2023) & (K Boxes)
Table 114. Asia-Pacific Rivaroxaban Tablets Sales Quantity by Application (2024-2029) & (K Boxes)
Table 115. Asia-Pacific Rivaroxaban Tablets Sales Quantity by Region (2018-2023) & (K Boxes)
Table 116. Asia-Pacific Rivaroxaban Tablets Sales Quantity by Region (2024-2029) & (K Boxes)
Table 117. Asia-Pacific Rivaroxaban Tablets Consumption Value by Region (2018-2023) & (USD Million)
Table 118. Asia-Pacific Rivaroxaban Tablets Consumption Value by Region (2024-2029) & (USD Million)
Table 119. South America Rivaroxaban Tablets Sales Quantity by Type (2018-2023) & (K Boxes)
Table 120. South America Rivaroxaban Tablets Sales Quantity by Type (2024-2029) & (K Boxes)
Table 121. South America Rivaroxaban Tablets Sales Quantity by Application (2018-2023) & (K Boxes)
Table 122. South America Rivaroxaban Tablets Sales Quantity by Application (2024-2029) & (K Boxes)
Table 123. South America Rivaroxaban Tablets Sales Quantity by Country (2018-2023) & (K Boxes)
Table 124. South America Rivaroxaban Tablets Sales Quantity by Country (2024-2029) & (K Boxes)
Table 125. South America Rivaroxaban Tablets Consumption Value by Country (2018-2023) & (USD Million)
Table 126. South America Rivaroxaban Tablets Consumption Value by Country (2024-2029) & (USD Million)
Table 127. Middle East & Africa Rivaroxaban Tablets Sales Quantity by Type (2018-2023) & (K Boxes)
Table 128. Middle East & Africa Rivaroxaban Tablets Sales Quantity by Type (2024-2029) & (K Boxes)
Table 129. Middle East & Africa Rivaroxaban Tablets Sales Quantity by Application (2018-2023) & (K Boxes)
Table 130. Middle East & Africa Rivaroxaban Tablets Sales Quantity by Application (2024-2029) & (K Boxes)
Table 131. Middle East & Africa Rivaroxaban Tablets Sales Quantity by Region (2018-2023) & (K Boxes)
Table 132. Middle East & Africa Rivaroxaban Tablets Sales Quantity by Region (2024-2029) & (K Boxes)
Table 133. Middle East & Africa Rivaroxaban Tablets Consumption Value by Region (2018-2023) & (USD Million)
Table 134. Middle East & Africa Rivaroxaban Tablets Consumption Value by Region (2024-2029) & (USD Million)
Table 135. Rivaroxaban Tablets Raw Material
Table 136. Key Manufacturers of Rivaroxaban Tablets Raw Materials
Table 137. Rivaroxaban Tablets Typical Distributors
Table 138. Rivaroxaban Tablets Typical Customers
List of Figures
Figure 1. Rivaroxaban Tablets Picture
Figure 2. Global Rivaroxaban Tablets Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Rivaroxaban Tablets Consumption Value Market Share by Type in 2022
Figure 4. 2.5mg/Tablet Examples
Figure 5. 10mg/Tablet Examples
Figure 6. 15mg/Tablet Examples
Figure 7. 20mg/Tablet Examples
Figure 8. Global Rivaroxaban Tablets Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 9. Global Rivaroxaban Tablets Consumption Value Market Share by Application in 2022
Figure 10. Hospital Examples
Figure 11. Clinic Examples
Figure 12. Drugstore Examples
Figure 13. Global Rivaroxaban Tablets Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 14. Global Rivaroxaban Tablets Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 15. Global Rivaroxaban Tablets Sales Quantity (2018-2029) & (K Boxes)
Figure 16. Global Rivaroxaban Tablets Average Price (2018-2029) & (US$/Box)
Figure 17. Global Rivaroxaban Tablets Sales Quantity Market Share by Manufacturer in 2022
Figure 18. Global Rivaroxaban Tablets Consumption Value Market Share by Manufacturer in 2022
Figure 19. Producer Shipments of Rivaroxaban Tablets by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 20. Top 3 Rivaroxaban Tablets Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Top 6 Rivaroxaban Tablets Manufacturer (Consumption Value) Market Share in 2022
Figure 22. Global Rivaroxaban Tablets Sales Quantity Market Share by Region (2018-2029)
Figure 23. Global Rivaroxaban Tablets Consumption Value Market Share by Region (2018-2029)
Figure 24. North America Rivaroxaban Tablets Consumption Value (2018-2029) & (USD Million)
Figure 25. Europe Rivaroxaban Tablets Consumption Value (2018-2029) & (USD Million)
Figure 26. Asia-Pacific Rivaroxaban Tablets Consumption Value (2018-2029) & (USD Million)
Figure 27. South America Rivaroxaban Tablets Consumption Value (2018-2029) & (USD Million)
Figure 28. Middle East & Africa Rivaroxaban Tablets Consumption Value (2018-2029) & (USD Million)
Figure 29. Global Rivaroxaban Tablets Sales Quantity Market Share by Type (2018-2029)
Figure 30. Global Rivaroxaban Tablets Consumption Value Market Share by Type (2018-2029)
Figure 31. Global Rivaroxaban Tablets Average Price by Type (2018-2029) & (US$/Box)
Figure 32. Global Rivaroxaban Tablets Sales Quantity Market Share by Application (2018-2029)
Figure 33. Global Rivaroxaban Tablets Consumption Value Market Share by Application (2018-2029)
Figure 34. Global Rivaroxaban Tablets Average Price by Application (2018-2029) & (US$/Box)
Figure 35. North America Rivaroxaban Tablets Sales Quantity Market Share by Type (2018-2029)
Figure 36. North America Rivaroxaban Tablets Sales Quantity Market Share by Application (2018-2029)
Figure 37. North America Rivaroxaban Tablets Sales Quantity Market Share by Country (2018-2029)
Figure 38. North America Rivaroxaban Tablets Consumption Value Market Share by Country (2018-2029)
Figure 39. United States Rivaroxaban Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Canada Rivaroxaban Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Mexico Rivaroxaban Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 42. Europe Rivaroxaban Tablets Sales Quantity Market Share by Type (2018-2029)
Figure 43. Europe Rivaroxaban Tablets Sales Quantity Market Share by Application (2018-2029)
Figure 44. Europe Rivaroxaban Tablets Sales Quantity Market Share by Country (2018-2029)
Figure 45. Europe Rivaroxaban Tablets Consumption Value Market Share by Country (2018-2029)
Figure 46. Germany Rivaroxaban Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. France Rivaroxaban Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. United Kingdom Rivaroxaban Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Russia Rivaroxaban Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Italy Rivaroxaban Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. Asia-Pacific Rivaroxaban Tablets Sales Quantity Market Share by Type (2018-2029)
Figure 52. Asia-Pacific Rivaroxaban Tablets Sales Quantity Market Share by Application (2018-2029)
Figure 53. Asia-Pacific Rivaroxaban Tablets Sales Quantity Market Share by Region (2018-2029)
Figure 54. Asia-Pacific Rivaroxaban Tablets Consumption Value Market Share by Region (2018-2029)
Figure 55. China Rivaroxaban Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Japan Rivaroxaban Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Korea Rivaroxaban Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. India Rivaroxaban Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Southeast Asia Rivaroxaban Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. Australia Rivaroxaban Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. South America Rivaroxaban Tablets Sales Quantity Market Share by Type (2018-2029)
Figure 62. South America Rivaroxaban Tablets Sales Quantity Market Share by Application (2018-2029)
Figure 63. South America Rivaroxaban Tablets Sales Quantity Market Share by Country (2018-2029)
Figure 64. South America Rivaroxaban Tablets Consumption Value Market Share by Country (2018-2029)
Figure 65. Brazil Rivaroxaban Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Argentina Rivaroxaban Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 67. Middle East & Africa Rivaroxaban Tablets Sales Quantity Market Share by Type (2018-2029)
Figure 68. Middle East & Africa Rivaroxaban Tablets Sales Quantity Market Share by Application (2018-2029)
Figure 69. Middle East & Africa Rivaroxaban Tablets Sales Quantity Market Share by Region (2018-2029)
Figure 70. Middle East & Africa Rivaroxaban Tablets Consumption Value Market Share by Region (2018-2029)
Figure 71. Turkey Rivaroxaban Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Egypt Rivaroxaban Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Saudi Arabia Rivaroxaban Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. South Africa Rivaroxaban Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. Rivaroxaban Tablets Market Drivers
Figure 76. Rivaroxaban Tablets Market Restraints
Figure 77. Rivaroxaban Tablets Market Trends
Figure 78. Porters Five Forces Analysis
Figure 79. Manufacturing Cost Structure Analysis of Rivaroxaban Tablets in 2022
Figure 80. Manufacturing Process Analysis of Rivaroxaban Tablets
Figure 81. Rivaroxaban Tablets Industrial Chain
Figure 82. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 83. Direct Channel Pros & Cons
Figure 84. Indirect Channel Pros & Cons
Figure 85. Methodology
Figure 86. Research Process and Data Source